Page last updated: 2024-11-06

phentolamine and Prostatic Neoplasms, Castration-Resistant

phentolamine has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

Phentolamine: A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
phentolamine : A substituted aniline that is 3-aminophenol in which the hydrogens of the amino group are replaced by 4-methylphenyl and 4,5-dihydro-1H-imidazol-2-ylmethyl groups respectively. An alpha-adrenergic antagonist, it is used for the treatment of hypertension.

Prostatic Neoplasms, Castration-Resistant: Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE.

Research Excerpts

ExcerptRelevanceReference
"Phentolamine has a simple chemical structure and is not a P-gp substrate."1.42Repurposing of phentolamine as a potential anticancer agent against human castration-resistant prostate cancer: A central role on microtubule stabilization and mitochondrial apoptosis pathway. ( Chang, WL; Chao, CC; Guh, JH; Ho, CH; Hsu, JL; Hsu, LC; Liu, SP, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ho, CH1
Hsu, JL1
Liu, SP1
Hsu, LC1
Chang, WL1
Chao, CC1
Guh, JH1

Other Studies

1 other study available for phentolamine and Prostatic Neoplasms, Castration-Resistant

ArticleYear
Repurposing of phentolamine as a potential anticancer agent against human castration-resistant prostate cancer: A central role on microtubule stabilization and mitochondrial apoptosis pathway.
    The Prostate, 2015, Volume: 75, Issue:13

    Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Repositioni

2015